Company
Team
CORPORATE GOVERNANCE
Platforms
Glycovirology
Diseases and Therapies Overview
pipeline
ProLectin Pipeline
Degenerative Disease pipeline
Resources
IN THE NEWS
Articles
Stroke video
faq
SCIENTIFIC PUBLICATIONS
investors
Company presentation
press releases
Research
financial
Contact US
$BIXT
Company
Platforms
Glycovirology
Diseases and Therapies Overview
Resources
Investors
Pipeline
contact us
NASH
Publications
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
go back